These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 28695554)

  • 1. The search for atrial fibrillation and its impact on public health.
    Lam A; Goulouti E; Roten L
    Swiss Med Wkly; 2017; 147():w14447. PubMed ID: 28695554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of atrial fibrillation burden in assessing thromboembolic risk.
    Zimetbaum P; Waks JW; Ellis ER; Glotzer TV; Passman RS
    Circ Arrhythm Electrophysiol; 2014 Dec; 7(6):1223-9. PubMed ID: 25516580
    [No Abstract]   [Full Text] [Related]  

  • 3. [Atrial fibrillation: Thromboembolic risk factor or marker? From concept to therapy].
    Le Heuzey JY
    Presse Med; 2017; 46(7-8 Pt 1):751-757. PubMed ID: 28757174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anticoagulation and atrial fibrillation. Putting the results of clinical trials into practice.
    Wipf JE
    West J Med; 1995 Aug; 163(2):145-52. PubMed ID: 7571562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Meta-analysis of CHADS2 versus CHA2DS2-VASc for predicting stroke and thromboembolism in atrial fibrillation patients independent of anticoagulation.
    Zhu WG; Xiong QM; Hong K
    Tex Heart Inst J; 2015 Feb; 42(1):6-15. PubMed ID: 25873792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Anticoagulation in atrial fibrillation. Strategies in special situations].
    Volkmann H; Walter M; Walter C; Vetter S
    Clin Res Cardiol Suppl; 2011 May; 6():58-65. PubMed ID: 22528179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent advances in oral anticoagulation for atrial fibrillation.
    Singh M; Adigopula S; Patel P; Kiran K; Khosla S
    Ther Adv Cardiovasc Dis; 2010 Dec; 4(6):395-407. PubMed ID: 20965952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Screening strategies for atrial fibrillation].
    Terrier J; Carballo S
    Rev Med Suisse; 2015 Oct; 11(490):1892, 1894-6, 1898. PubMed ID: 26665658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel oral anticoagulants for the prevention of thromboembolism in patients with atrial fibrillation.
    Lang NN; Connelly DT
    J R Coll Physicians Edinb; 2013; 43(2):151-8. PubMed ID: 23734359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atrial fibrillation: state of the art.
    Hasun M; Gatterer E; Weidinger F
    Wien Klin Wochenschr; 2014 Nov; 126(21-22):692-704. PubMed ID: 25409952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral anticoagulant use around the time of atrial fibrillation ablation: a review of the current evidence of individual oral anticoagulant use for periprocedural atrial fibrillation ablation thromboembolic prophylaxis.
    Garton AB; Dudzinski J; Kowey PR
    J Cardiovasc Electrophysiol; 2014 Dec; 25(12):1411-8. PubMed ID: 25216104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thromboembolic complications in atrial fibrillation.
    Petersen P
    Stroke; 1990 Jan; 21(1):4-13. PubMed ID: 2405547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atrial fibrillation in New Zealand primary care: Prevalence, risk factors for stroke and the management of thromboembolic risk.
    Tomlin AM; Lloyd HS; Tilyard MW
    Eur J Prev Cardiol; 2017 Feb; 24(3):311-319. PubMed ID: 27798365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Striking a balance between the risks and benefits of anticoagulation bridge therapy in patients with atrial fibrillation: clinical updates and remaining controversies.
    Garwood CL; Hwang JM; Moser LR
    Pharmacotherapy; 2011 Dec; 31(12):1208-20. PubMed ID: 22122182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Anticoagulation and atrial fibrillation].
    Prieto S; Young P; Ceresetto JM; Bullorsky EO
    Medicina (B Aires); 2011; 71(3):274-82. PubMed ID: 21745781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of Anticoagulation for Thromboembolic Prophylaxis in Patients With Atrial High-Rate Episodes on Device Monitoring: A Narrative Review.
    Leung ANW; Bhat A
    Am J Cardiol; 2024 Jan; 211():183-190. PubMed ID: 37944778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delaying cardioversion following 4-week anticoagulation in case of persistent atrial fibrillation after a transcatheter ablation procedure to reduce silent cerebral thromboembolism: a single-center pilot study.
    Pianelli M; Scaglione M; Anselmino M; Caponi D; Garcia P; Cesarani F; Toso E; Raimondo C; Halimi F; Leclercq JF; Gaita F
    J Cardiovasc Med (Hagerstown); 2011 Nov; 12(11):785-9. PubMed ID: 21941200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Percutaneous closure of the left atrial appendage for prevention of thromboembolism in atrial fibrillation for patients with contraindication to or failure of oral anticoagulation: a single-center experience.
    Faustino A; Paiva L; Providência R; Trigo J; Botelho A; Costa M; Leitão-Marques A
    Rev Port Cardiol; 2013 Jun; 32(6):461-71. PubMed ID: 23639325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lone atrial fibrillation and anticoagulant therapy.
    More RS; Brack MJ; Gershlick AH
    Clin Cardiol; 1993 Jun; 16(6):504-6. PubMed ID: 8358885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Antithrombotic therapy in atrial fibrillation with ximelagatran: can it be an alternative to warfarin?].
    Selçuk H; Selçuk MT; Maden O
    Anadolu Kardiyol Derg; 2007 Mar; 7(1):54-8. PubMed ID: 17347079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.